Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • GenePool
    Registered Vendor
    • Mar 2014
    • 18

    The Cancer Genome Atlas (TCGA) available in GenePool

    GenePool is Station X’s software environment for the management, analysis and sharing of cohort-scale genomics data. GenePool makes it easy for translational and clinical researchers to make sense of patient-derived genomics data, particularly mutation and expression data generated from sequencing platforms.

    One of the highlights of our Premium Content collection is our version of The NIH/NHGRI Cancer Genome Atlas (TCGA) project - organized, curated and presented in an analysis platform you can use instantly.

    The TCGA is a landmark project to molecularly characterize more than 30 types of human cancers using advanced genomic technologies. The data represents over 16,000 patients with >100,000 assays including expression of genes, splicings, exons and miRNAs, somatic mutations, copy number, methylation, protein expression, etc.*

    Although the project is a tremendously rich resource for cancer research, the volume and complexity of the TCGA data makes it difficult for scientists to extract full value from it. Recognizing this, Station X has consolidated the public access TCGA genomic data, curated the associated sample- and patient-derived clinical information and integrated it all in GenePool, our cloud-based genome management and analysis platform. This means an investigator can be exploring the TCGA resource in minutes without needing to download software or data, and without requiring IT or bioinformatics support.

    GenePool provides instant access to the following TCGA assays:

    *Somatic Mutations (per patient derived from exome sequencing of Tumor and matched Blood-Normal sample)
    *RNA-Seq (genes, isoforms, exons, splice junctions)
    *miRNA-Seq
    *Protein Expression (array-based)
    *DNA Methylation (chip-based)
    *Copy Number (chip-based)

    Station X offers the gene-level RNA-Seq data for all cancer indications to the community as a freely available resource to the community. The rest of the data is made available to GenePool subscribers as premium content. The Breast Cancer (BRCA) data for all assays is available to the community as a free preview.

    Click on the following links for more information on GenePool, full details of our free content, our premium content, and to take advantage of our special discounts available if you mention you heard about us through SeqAnswers.com.


    *In keeping with dbGAP requirements, GenePool contains only open-access TCGA data. Access to the controlled-access portions of TCGA always requires application to dbGAP.


    ------------------------------
    GenePool is making genomics data management, analysis, and sharing easier!
    Products @ www.stationxinc.com
    Last edited by GenePool; 01-12-2015, 02:57 PM. Reason: embedded links changed

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    Yesterday, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:04 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-02-2026, 11:08 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Working...